TRCT
AMRI

Tower Research Capital (TRC)’s Albany Molecular Research Inc AMRI Stock Holding History

Tower Research Capital (TRC)’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-146
Closed -$2K – 3953
2017
Q1 		$2K Buy
+146
New +$2.39K ﹤0.01% 2734
2016
Q3 		– Sell
-677
Closed -$9K – 5088
2016
Q2 		$9K Buy
+677
New +$9.88K ﹤0.01% 2976
2016
Q1 		– Sell
-1,997
Closed -$40K – 5500
2015
Q4 		$40K Buy
1,997
+613
+44% +$11.6K 0.01% 700
2015
Q3 		$24K Sell
1,384
-4,737
-77% -$96.4K ﹤0.01% 1593
2015
Q2 		$124K Buy
6,121
+5,057
+475% +$97.6K 0.01% 647
2015
Q1 		$19K Buy
+1,064
New +$18.1K ﹤0.01% 2317
2014
Q4 		– Sell
-2
Closed – – 5152
2014
Q3 		$0 Buy
+2
New +$41 ﹤0.01% 5204
2014
Q2 		– Sell
-2,035
Closed -$38K – 5033
2014
Q1 		$38K Sell
2,035
-1,342
-40% -$18.5K ﹤0.01% 1304
2013
Q4 		$34K Buy
3,377
+425
+14% +$5.14K 0.01% 1767
2013
Q3 		$38K Sell
2,952
-2,947
-50% -$36.3K ﹤0.01% 2171
2013
Q2 		$70K Buy
+5,899
New +$63.9K 0.01% 704

Other funds holding AMRI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Tower Research Capital (TRC)'s AMRI Position: Q2 2017 in Review

Tower Research Capital (TRC) sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 146 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in AMRI in Q2 2013 and held it in 11 quarters. The position peaked at $124K in Q2 2015. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

  • Tower Research Capital (TRC) reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 146 Albany Molecular Research Inc shares in Q2 2017, an estimated $2K.
  • Tower Research Capital (TRC) first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s Albany Molecular Research Inc position peaked at $124K in Q2 2015.
  • 136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.